Colorectal cancer survivorship

The formal definition of survivorship, used by the National Cancer Institute and reflected in Australian guidance, begins at the moment of diagnosis and continues through the rest of life. In everyday conversation, though, the word usually refers to the phase that opens when active treatment finishes — the last operation, the final chemotherapy cycle, the last radiotherapy session — and the focus shifts.

Survivorship is its own clinical phase, with its own questions:

• What is being checked at follow-up, and when?
• What lingering effects from treatment can I expect, and how long will they last?
• Is the cancer gone, and what would I notice if it came back?
• What can I do to look after my long-term health from here?
• What does this mean for my family?
• How do I go back to work, and how do I make sense of what I have been through?

The honest framing: most people emerge changed by the experience but well. Many describe a slow recalibration over months to a couple of years, after which life takes a steady shape again. There is no one timeline.

After curative-intent treatment, structured surveillance runs for 5 years. The aim is to catch a recurrence — if one happens — early enough that something can be done about it. The pattern in Australia, based on Cancer Council Australia / NHMRC-endorsed guidelines, typically looks like this:

Typical surveillance schedule after curative bowel cancer treatment

• Clinical review (history and examination) — every 3 to 6 months for the first 2 to 3 years, then every 6 to 12 months until 5 years.
• CEA blood test — every 3 to 6 months for 3 years, then every 6 months in years 4 and 5. CEA is a tumour marker that can rise before a recurrence shows on scans.
• CT scan of the chest, abdomen and pelvis — usually once a year for 5 years (more often if higher-risk features).
• Colonoscopy — typically within the first year after surgery (if a complete colonoscopy was not possible before the operation, this is sometimes done sooner). Repeat colonoscopy is then performed at 3 years, then every 5 years thereafter — adjusted up if polyps are found.
• Pelvic MRI — used in some rectal cancer surveillance protocols, particularly for patients under Watch and Wait, where the rectum has been preserved.

For more on the detail — what each test is, what the numbers mean, why CEA can rise without indicating recurrence, and what happens after 5 years — see the dedicated bowel cancer follow-up surveillance page. After 5 years, most patients return to standard bowel cancer surveillance (typically colonoscopy every 5 years for life), under the care of a GP, surgeon or gastroenterologist.

The most common physical lingering effect after bowel cancer treatment is a change in bowel function. This is heavily shaped by what part of the bowel was removed and whether radiotherapy was given.

• After right-sided colon surgery (right hemicolectomy), most people end up with bowel motions that are looser or more frequent for the first weeks or months and then settle close to normal. The ileocaecal valve is removed and the small bowel now joins the colon further along — small adjustments can persist.
• After left-sided and sigmoid colon surgery, bowel function usually returns to near-normal within a few months.
• After subtotal colectomy (most of the colon removed, small bowel joined to the rectum), expect 3 to 6 motions a day initially. Most people settle to 2 to 4 over the first year. Hydration and electrolytes matter — the colon's water-absorbing role is now the small bowel's job. A psyllium husk supplement (Metamucil) is often helpful to shape stool.
• After rectal cancer surgery (anterior resection), Low Anterior Resection (LAR) syndrome describes the cluster of bowel changes that can follow: frequent small motions (sometimes 8 to 12 a day), urgency, fragmentation (passing stool in several small visits over an hour or two), gas leakage, occasional accidents, and clustering of motions after eating. Most people improve substantially over the first 12 to 18 months, and many return close to baseline. Pelvic floor physiotherapy is one of the most effective interventions.
• With a stoma, the practical adjustment continues for months. See life with a stoma.

If bowel symptoms are interfering with daily life beyond what feels reasonable, it is worth raising at follow-up. Antidiarrhoeal medication, bulking agents, dietary adjustments, pelvic floor physiotherapy, biofeedback, transanal irrigation, and (for severe persistent LAR syndrome) sacral nerve stimulation are all available. The clinical reality is that most patients improve more than they expected — but the improvement is rarely fast.

Beyond the bowel, several other effects from treatment can persist or appear later. None of these are reasons that treatment should not have been given — but they are part of the survivorship picture, and recognising them is the first step in managing them.

Longer-term effects to be aware of

• Oxaliplatin neuropathy. Numbness and pins-and-needles in fingers and toes — usually improves over the first 1 to 2 years but can be lasting. Most people adapt; some need help with fine motor tasks (buttons, jewellery) for longer. See chemotherapy for bowel cancer.
• Pelvic radiotherapy late effects — more frequent or urgent bowel motions; bladder irritability; vaginal dryness and narrowing in women; erectile and ejaculatory changes in men; pelvic bone thinning. Treatable and worth raising. See radiotherapy for rectal cancer.
• Sexual function. Both pelvic surgery and pelvic radiotherapy can affect sexual function for both sexes. Effective treatments exist — pharmacological, mechanical, and counselling-based. Many people do not raise it; almost all of them wish they had. Please ask your surgeon, oncologist, or GP.
• Fertility. If you are of reproductive age and chemotherapy or pelvic radiotherapy were given, fertility may be permanently reduced. Conversations about pregnancy should be informed by an assessment of ovarian reserve or sperm parameters where relevant.
• Hormonal effects. Early menopause is common after chemotherapy in younger women — hot flushes, vaginal dryness, mood changes, and bone density implications need their own management. Men may have low testosterone after pelvic treatment.
• Bone density. Cancer treatments, particularly pelvic radiotherapy and treatment-induced menopause, accelerate bone thinning. A DXA scan and consideration of bone-protective treatment is part of long-term care for some patients.
• Fatigue. Persistent fatigue beyond the immediate treatment phase is common. Graded exercise, attention to sleep, and addressing untreated anaemia or thyroid issues all help. If fatigue is severe and persistent, it is worth a structured medical assessment.
• Cognitive changes ("chemo brain"). Some people describe word-finding difficulty and concentration issues for some months after chemotherapy. Most improve over the first year; for the minority who do not, neuropsychological assessment and rehabilitation strategies are available.
• Surgical adhesions. Internal scar tissue inside the abdomen can occasionally cause partial blockage of the small bowel years later, with cramping pain and vomiting. Usually settles with conservative management; occasionally needs surgery.
• Parastomal hernia / incisional hernia. Late hernias around a stoma or through a surgical scar occur in a substantial minority. Managed with support garments, or surgically if troublesome.

The pattern across all of these is the same: most improve over the first 12 to 18 months; a minority have persistent issues that respond to targeted treatment if raised. The hardest barrier is often patients not knowing the effect is recognised, expected, and treatable.

Several lifestyle factors influence long-term outcomes after bowel cancer — and they are the ones you can actually control. The evidence here is large and consistent:

• Regular physical activity — independently linked with better outcomes in bowel cancer survivors. Aim for 30 to 60 minutes most days, combining cardiovascular activity (walking, cycling, swimming) and some resistance work. Even modest activity matters; you do not need to be an athlete.
• Healthy weight. Excess body fat — particularly central — is associated with poorer outcomes. Gradual, modest weight loss (5 to 10 per cent) if you are above your healthy range is worthwhile.
• Diet. A plant-forward Mediterranean-style eating pattern — plenty of vegetables, fruit, wholegrains and legumes, with red meat limited and processed meat minimised — is what the evidence supports. See diet for bowel cancer.
• Alcohol low or none. No more than 10 standard drinks a week (Australian guidelines), with several alcohol-free days. Less is better.
• Don't smoke. If you do, this is the highest-yield change. Quitting at any stage benefits long-term outcomes substantially.
• Sun protection — skin cancer rates in Australia are high regardless of bowel cancer history. Some chemotherapy increases sun sensitivity for months afterwards.
• Sleep — addressing untreated insomnia, sleep apnoea, or night-time anxiety has flow-on effects on fatigue, mood, and physical recovery.

None of this is a guarantee against recurrence. People who do all of it still sometimes have the cancer come back. But across large populations, these factors shift the odds — they are levers worth pulling.

The emotional experience of survivorship is often more challenging than the treatment phase. During treatment there is a structure: appointments, scans, the next infusion, the next surgery. Afterwards, the structure thins. The body is healing, the calendar is emptier, and the mind has space to consider what just happened.

Common patterns:

• Recurrence anxiety — worry that the cancer will come back. For most people this fades steadily over the first year or two. For some, it spikes around scan and follow-up appointments — sometimes weeks beforehand. Mild ongoing vigilance is normal; persistent anxiety that controls your week needs support.
• A "delayed" emotional reaction — feelings that were suppressed during active treatment surface afterwards. People sometimes feel worse 3 to 6 months after treatment ends than they did during it. This is common, recognised, and improves.
• Grief — for the body that was, the future that was assumed, the energy that has not yet returned. Grief is appropriate; it is not depression. Talking about it openly often takes its weight.
• Relationship reshuffles. Partners, friends and family often relate differently to you after a serious illness. Sometimes closer, sometimes more distant, often confused. Honest conversations help — including the conversation that says I don't always need you to ask how I am.
• Identity and meaning. Many people find the experience prompts a re-examination of work, priorities, and how they spend their time. The change is not always negative — but it is rarely small.

Family screening. Bowel cancer in a close family member affects the screening recommendations for first-degree relatives — parents, siblings and children. The general pattern is that first-degree relatives have around double the average lifetime risk and should consider starting screening earlier than the standard NBCSP age range. If you were diagnosed under 50, or if your pathology was mismatch-repair-deficient, hereditary syndromes such as Lynch syndrome should be considered. See family screening for bowel cancer for the specific recommendations and how to discuss it with relatives.

Return to work. Most people return to work, though the timing varies. Office-based work often resumes 4 to 8 weeks after surgery, sometimes earlier if working from home is an option; physically demanding work usually needs 8 to 12 weeks. A graded return — reduced hours, modified duties, working from home some days — is common and usually well-received by employers. Australian law prevents employers from discriminating on the basis of cancer history. Income protection insurance, sick leave entitlements, and Centrelink Sickness Allowance can bridge financial gaps. Your hospital social worker is a useful resource for navigating this.

Travel insurance. Travel insurance for those with a cancer history requires specific declarations and may cost more — but it is available. Use a broker or specialist insurer.

Life and income insurance. Existing policies remain valid. New policies may have exclusions or loadings for a period after diagnosis. An independent financial adviser is the right source of personalised advice.

Talking to children and grandchildren. If you have not yet — many people put it off. Children handle truthful, age-appropriate information better than they handle silence and the sense that something is being hidden. The Cancer Council has good resources written for this specifically.